Log In
Print
BCIQ
Print
Print this Print this
 

IVIG

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionIntravenous immunoglobulin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationImmunodeficiency
Indication DetailsTreat immunodeficiency
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today